Dr Reddys Laboratories
Dr Reddys Laboratories Ltd has informed BSE that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended December 31, 2016, with the United States Securities Exchange Commission on February 10, 2017. A copy
1.43 PM Feb 13th
The Exchange has sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing in The Financial Express on January 26, 2017 titled "Korean biotech firm Mezzion Pharma files suit against Dr Reddys Laboratories."The reply is awaited.
12.37 PM Jan 27th
Dr. Reddys Laboratories Limited has informed the Exchange regarding a press release dated January 23, 2017, titled "Dr. Reddys Q3-FY17 Earnings Call Notification".Dr. Reddys to release Q3 FY17 results on Feb 4, 2017 Earnings call slated for Feb 4, 6.30 PM IST / 8.00 AM EST
11.29 AM Jan 23rd
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.